4.3 Article

Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia

Related references

Note: Only part of the references are listed.
Review Immunology

The Aryl Hydrocarbon Receptor and Tumor immunity

Ping Xue et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance

Dilana Staudt et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Biochemistry & Molecular Biology

Understanding of leukemic stem cells and their clinical implications

Xuefei Wang et al.

MOLECULAR CANCER (2017)

Review Biochemistry & Molecular Biology

Targeting acute myeloid leukemia stem cell signaling by natural products

Kodappully Sivaraman Siveen et al.

MOLECULAR CANCER (2017)

Review Oncology

Acute myeloid leukemia: a comprehensive review and 2016 update

I. De Kouchkovsky et al.

BLOOD CANCER JOURNAL (2016)

Article Education, Scientific Disciplines

Mutations in AML: prognostic and therapeutic implications

Courtney D. DiNardo et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Editorial Material Dermatology

FICZ: A Messenger of Light in Human Skin

Deeba N. Syed et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Review Medicine, General & Internal

Acute Myeloid Leukemia

Hartmut Doehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis

Francisco J. Quintana et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells

Anthony E. Boitano et al.

SCIENCE (2010)

Article Medicine, General & Internal

Prognostically useful gene-expression profiles in acute myeloid leukemia

PJM Valk et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)